Status:
WITHDRAWN
The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars
Lead Sponsor:
Maternal and Child Health Hospital of Foshan
Conditions:
Cicatrix
Eligibility:
FEMALE
21-35 years
Phase:
PHASE2
Brief Summary
The study is to investigate the long-term efficacy of perinatal tissue mesenchyme stem cells treatment on the appearance of a caesarean scar as compared to a similar untreated scar.
Detailed Description
This trial is a continuation of the investigators' previous clinical trial (NCT02772289). In the previous three-arm randomized clinical trial involving women with primiparous singleton pregnancies, th...
Eligibility Criteria
Inclusion
- Primiparous women receiving cesarean delivery
- Ages between 21-35 years
- Gestation ages ≥ 37 weeks and \< 42 weeks
- Willing to give and sign an informed consent form and a photographic release form
- Willing to comply with study dosing and complete the entire course of the study
Exclusion
- Any systemic uncontrolled disease
- Recent or current cancer
- History or presenting with a keloid formation
- Wounds or local disease in treatment area
- Planning any other cosmetic procedure to the study area during the study period
- Smoking
Key Trial Info
Start Date :
May 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04034615
Start Date
May 20 2021
End Date
June 1 2022
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternal and Child Health Hospital of Foshan
Foshan, Guangdong, China, 528000